SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-029040
Filing Date
2013-05-15
Accepted
2013-05-15 09:44:08
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v342019_10q.htm 10-Q 296209
2 EX-31.1 v342019_ex31-1.htm EX-31.1 10044
3 EX-31.2 v342019_ex31-2.htm EX-31.2 10215
4 EX-32 v342019_ex32.htm EX-32 6527
  Complete submission text file 0001144204-13-029040.txt   2198043

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20130331.xml EX-101.INS 202639
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20130331.xsd EX-101.SCH 17878
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20130331_cal.xml EX-101.CAL 39405
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20130331_def.xml EX-101.DEF 113608
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20130331_lab.xml EX-101.LAB 186019
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20130331_pre.xml EX-101.PRE 135811
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 13844110
SIC: 2834 Pharmaceutical Preparations